Zhijie Xu
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 31
- MicroRNA in disease regulation 28
- Cancer, Hypoxia, and Metabolism 14
- Molecular Biology top 2%
- RNA modifications and cancer 39
- Epigenetics and DNA Methylation 28
- Extracellular vesicles in disease 15
- Circular RNAs in diseases 15
- Oncology top 5%
- Immunology top 5%
-
- Ferroptosis and cancer prognosis 45
- Journals
- Nucleic Acids Research (2 papers)Journal of Biological Chemistry (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Zhijie Xu
195 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Cancer Research 1.8k
- Molecular Biology 3.1k
- Oncology 729
- Immunology 564
- Pulmonary and Respiratory Medicine 871
Countries citing papers authored by Zhijie Xu
This map shows the geographic impact of Zhijie Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhijie Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhijie Xu more than expected).
Fields of papers citing papers by Zhijie Xu
This network shows the impact of papers produced by Zhijie Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhijie Xu. The network helps show where Zhijie Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhijie Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 4 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 23 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 4 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 8 | |
| 11 | Identification of m6A-Associated Gene DST as a Prognostic and Immune-Associated Biomarker in Breast Cancer Patients | 2022 | 5 |
| 12 | 2022 | 7 | |
| 13 | 2022 | 20 | |
| 14 | 2021 | 12 | |
| 15 | 2021 | 23 | |
| 16 | 2021 | 73 | |
| 17 | 2020 | 47 | |
| 18 | 2020 | 2 | |
| 19 | 2019 | 14 | |
| 20 | 2019 | 46 |
About Zhijie Xu
Zhijie Xu is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 208 papers that have together received 4.7k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (45 papers), RNA modifications and cancer (39 papers), Cancer-related molecular mechanisms research (31 papers), MicroRNA in disease regulation (28 papers), Epigenetics and DNA Methylation (28 papers), Extracellular vesicles in disease (15 papers), Circular RNAs in diseases (15 papers) and Cancer, Hypoxia, and Metabolism (14 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (3.1k citations) and Oncology (729 citations). Zhijie Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yuanliang Yan, Zhicheng Gong, Shuangshuang Zeng, Long Qian, Lunquan Sun, Qiuju Liang, Bi Peng, Jie Wei, Shuang Dai and Yuan Cai. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.